— Know what they know.
Not Investment Advice
Also trades as: EMBLA.CO (CPH) · $vol 0M · OSSUY (OTC) · $vol 0M

OSSFF OTC

Embla Medical hf.
1W: +0.0% 1M: -0.4% 3M: +9.2% YTD: -14.8% 1Y: -5.6% 3Y: -11.2% 5Y: -37.5%
$4.53
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 60 · $1.9B mcap · 170M float · 0.0000% daily turnover · Short 88% of daily vol

Balance Sheet Trends

Total Assets
$1.7B +12.6% ▲
5Y CAGR: +7.5%
Total Liabilities
$851M +10.4% ▲
5Y CAGR: +5.8%
Shareholders Equity
$891M +14.6% ▲
5Y CAGR: +9.2%
Cash & Investments
$103M +19.0% ▲
5Y CAGR: +0.0%
Total Debt
$695M +39.1% ▲
5Y CAGR: +7.5%
Net Debt
$593M +43.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$85M$77M$73M$86M$103M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$85M$77M$73M$86M$103M
Net Receivables$107M$117M$133M$131M$154M
Inventory$104M$132M$136M$143M$166M
Other Current Assets$8M$9M$16M$14M$17M
Total Current Assets$318M$349M$376M$397M$458M
Property, Plant & Equip.$182M$179M$186M$200M$243M
Goodwill & Intangibles$703M$742M$757M$873M$943M
Long-Term Investments$17M$17M$25M$23M$32M
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$931M$981M$1.0B$1.2B$1.3B
Total Assets$1.2B$1.3B$1.4B$1.6B$1.7B
— Liabilities —
Accounts Payable$27M$29M$31M$27M$33M
Short-Term Debt$67M$87M$43M$53M$96M
Deferred Revenue$3M$3M$3M$3M$8M
Other Current Liabilities$39M$65M$57M$60M$92M
Total Current Liabilities$186M$237M$196M$209M$310M
Long-Term Debt$262M$278M$312M$329M$446M
Other Non-Current Liab.$18M$23M$24M$56M-$125M
Total Non-Current Liabilities$437M$457M$493M$561M$541M
Total Liabilities$623M$694M$689M$770M$851M
— Equity —
Common Stock$5M$5M$5M$5M$5M
Retained Earnings$592M$640M$700M$759M$843M
Accumulated OCI-$46M-$70M-$64M-$75M-$51M
Total Stockholders Equity$622M$636M$702M$777M$891M
Total Liabilities & Equity$1.2B$1.3B$1.4B$1.6B$1.7B
— Key Metrics —
Total Debt$448M$481M$468M$500M$695M
Net Debt$363M$404M$395M$414M$593M
Total Investments$17M$17M$25M$23M$32M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms